Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial. (Q39497146)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial. |
scientific article |
Statements
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial (English)
Jamal Suleiman
Barry S Zingman
Ricardo Sobhie Diaz
Jose Valdez Ramalho Madruga
Edwin DeJesus
Jihad Slim
Carmen Mak
Erin Lee
Michael C McCarthy
Lisa M Dunkle
1 February 2010